Grisselle Ortiz Rivera
General Practice · Morovis, PRNPI 1013947423
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Ipsen Biopharmaceuticals, Inc. That places this record below the midpoint for general practice clinicians in PR, where the typical reported total is $178.
Across 2 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$29
Across 126 payments — averaging $5673.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$672K
- Intercept Pharma Europe Ltd.$43K
What the payments were for
- Food & beverage$29100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $29 |
How this compares
$29 in reported general payments places this provider in the 10th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $55,655 |
| JardianceEmpagliflozin | 62 | $52,477 |
| SynthroidLevothyroxine Sodium | 721 | $42,856 |
| TrulicityDulaglutide | 36 | $35,420 |
| JanumetSitagliptin Phos/Metformin Hcl | 42 | $27,873 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 40 | $27,446 |
| JanuviaSitagliptin Phosphate | 30 | $20,780 |
| FarxigaDapagliflozin Propanediol | 24 | $17,597 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 24 | $17,159 |
| JentaduetoLinagliptin/Metformin Hcl | 32 | $16,474 |
| XareltoRivaroxaban | 15 | $15,194 |
| TradjentaLinagliptin | 24 | $14,839 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $12,444 |
| Losartan Potassium | 934 | $8,933 |
| LantusInsulin Glargine,hum.Rec.Anlog | 94 | $8,725 |
Paid to pharmacies, not to this prescriber.
Other general practice in Morovis
- Wilfredo CuevasSan Lorenzo$530K
- Julio BacoMayaguez$268K
- Soria Diaz BaezPonce$192K
- Carlos RomanCanovanas$140K
- William E TorresSan Juan$86K
- Rafael Mendoza RodriguezPonce$77K
- Frank Perez NogueiraSan German$70K
- Vivian Tamayo AgraitSan Juan$64K
- William Soto AvilesToa Baja$63K
- Jessica RosarioSanturce$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.